Table 1

Baseline characteristics of patients with diabetes mellitus in the MRC/BHF heart protection study

Characteristic at entry Type 1 (n=615) Type 2 (n=5348)
Disease history
 Myocardial infarction30  (5%)1095  (20%)
 Other CHD31 (5%)822 (15%)
 Other cardiovascular124 (20%)948 (18%)
 No cardiovascular430 (70%)2483 (46%)
Treated hypertension118 (19%)2279 (43%)
Duration of diabetes (years)
28.6 (0.5)9.3 (0.1)
Age (years)52.6 (0.3)63.2 (0.1)
 ⩽ 65564 (92%)3082 (58%)
 > 6551 (8%)2266 (42%)
Total cholesterol (mmol/l)
5.52 (0.04)5.68 (0.01)
 ⩽ 5.5315 (51%)2464 (46%)
 > 5.5 ⩽ 7.0257 (42%)2349 (44%)
 > 7.043 (7%)535 (10%)
LDL cholesterol (mmol/l)1-150
3.01 (0.03)3.24 (0.01)
 ⩽ 3.0330 (54%)2131 (40%)
 > 3.0 ⩽ 3.5113 (18%)1306 (24%)
 > 3.5172 (28%)1911 (36%)
HDL cholesterol (mmol/l)1-150
1.40 (0.02)1.02 (0.00)
 ⩽ 1.096 (16%)3023 (57%)
 > 1.0519 (84%)2325 (43%)
Triglycerides (mmol/l)1.24 (0.03)2.38 (0.02)
 ⩽ 2.0526 (86%)2690 (50%)
 > 2.089 (14%)2658 (50%)
HbA1c (%)1-151 7.90 (0.09)7.04 (0.03)
 ⩽ 7.0235 (38%)3025 (57%)
 > 7.0379 (62%)2318 (43%)
  • Values are either n (%) or mean (SE).

  • 1-150 Corresponding differences between those with type 1 and type 2 diabetes were seen in blood concentrations of apolipoprotein B (1.01 (0.01) g/lv 1.11 (0.003) g/l) and of apolipoprotein A1 (1.33 (0.01) g/l v 1.18 (0.003) g/l).

  • 1-151 HbA1C was measured by a turbidimetric method on Beckman Synchron CX autoanalysers (manufacturer's normal range 2.9–4.6%).